89bio Company Insiders

ETNB Stock  USD 10.57  0.15  1.40%   
About 75 percent of all 89bio's insiders are aggressively buying. The analysis of the overall insider sentiment regarding 89bio Inc suggests that quite a large number of insiders are very bullish. 89bio employs about 70 people. The company is managed by 14 executives with a total tenure of roughly 164 years, averaging almost 11.0 years of service per executive, having 5.0 employees per reported executive.

Insider Sentiment 75

 Mostly Buying

 
Selling
 
Buying

Latest Trades

2025-01-30Ra Capital Management, L.P.Acquired 5714285 @ 8.75View
2025-01-21Charles McwherterAcquired 5000 @ 6.55View
2025-01-15Quoc Le-NguyenDisposed 10963 @ 6.49View
2024-12-06Rohan PalekarAcquired 5000 @ 7.89View
2024-12-05Charles McwherterAcquired 10000 @ 8View
2024-11-22Rohan PalekarAcquired 10000 @ 8.35View
2024-03-04Ra Capital Management, L.P.Acquired 1350000 @ 15.35View
2024-02-26Rohan PalekarDisposed 4477 @ 10.76View
Monitoring 89bio's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in 89bio Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

89bio's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with 89bio's future performance. Based on our forecasts, it is anticipated that 89bio will maintain a workforce of about 70 employees by March 2025.
 
Covid

89bio Management Team Effectiveness

The company has return on total asset (ROA) of (0.4136) % which means that it has lost $0.4136 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7331) %, meaning that it created substantial loss on money invested by shareholders. 89bio's management efficiency ratios could be used to measure how well 89bio manages its routine affairs as well as how well it operates its assets and liabilities. As of February 18, 2025, Return On Tangible Assets is expected to decline to -0.23. In addition to that, Return On Capital Employed is expected to decline to -0.25. At present, 89bio's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 3.3 M, whereas Net Tangible Assets are forecasted to decline to about 122 M.
The current year's Common Stock Shares Outstanding is expected to grow to about 85.9 M, whereas Net Loss is forecasted to decline to (96.4 M).

89bio Workforce Comparison

89bio Inc is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 2,592. 89bio holds roughly 70.0 in number of employees claiming about 2.7% of equities under Health Care industry.

89bio Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific 89bio insiders, such as employees or executives, is commonly permitted as long as it does not rely on 89bio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, 89bio insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2025-03-01
2.5556
23
9
 8,945,635 
 50,959 
2024-12-01
1.0
4
4
 3,275,000 
 312,955 
2024-09-01
0.4286
3
7
 442,700 
 21,386 
2024-06-01
1.0
3
3
 1,501,150 
 2,894,618 
2024-03-01
1.1765
20
17
 3,272,300 
 96,640 
2023-12-01
1.0
2
2
 1,131,081 
 100,000 
2023-09-01
0.0833
1
12
 12,500 
 44,635 
2023-06-01
0.6667
8
12
 156,657 
 168,784 
2023-03-01
0.963
26
27
 3,637,358 
 105,174 
2022-12-01
2.0
2
1
 1,181,741 
 3,113 
2022-09-01
2.0
10
5
 8,656,532 
 117,724 
2022-03-01
1.5833
19
12
 581,700 
 122,409 
2021-12-01
0.6667
4
6
 46,000 
 42,000 
2021-09-01
0.8333
5
6
 28,000 
 42,000 
2021-06-01
1.7778
16
9
 963,832 
 62,850 
2021-03-01
1.7778
16
9
 592,154 
 122,904 
2020-12-01
0.8
8
10
 29,890 
 1,746,192 
2020-09-01
1.3333
4
3
 1,793,180 
 412,500 
2019-12-01
0.8235
14
17
 12,750,403 
 56,713,553 

89bio Notable Stakeholders

A 89bio stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as 89bio often face trade-offs trying to please all of them. 89bio's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting 89bio's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Annie MBAVP CommunicationsProfile
Michael BaldwinVP QualityProfile
Harry MDChief OfficerProfile
Francis SarenaChief OfficerProfile
Rohan PalekarCEO DirectorProfile
Quoc LeNguyenChief QualityProfile
Shiva CPASenior OfficerProfile
Shiva NatarajanSenior OfficerProfile
Amanda HillVP CultureProfile
Melissa AbelVP CommunicationsProfile
Ryan MartinsChief OfficerProfile
Paul ShinSenior OperationsProfile
Yun BaiManufacturing ChemistryProfile
Amanda KuriharaVice CultureProfile

About 89bio Management Performance

The success or failure of an entity such as 89bio Inc often depends on how effective the management is. 89bio management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of 89bio management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the 89bio management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.21)(0.23)
Return On Capital Employed(0.24)(0.25)
Return On Assets(0.21)(0.23)
Return On Equity(0.30)(0.32)
Please note, the presentation of 89bio's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, 89bio's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of 89bio's management manipulating its earnings.

89bio Workforce Analysis

Traditionally, organizations such as 89bio use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare 89bio within its industry.

89bio Manpower Efficiency

Return on 89bio Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee2M
Net Loss Per Executive10.2M
Working Capital Per Employee8.1M
Working Capital Per Executive40.3M

Complementary Tools for 89bio Stock analysis

When running 89bio's price analysis, check to measure 89bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 89bio is operating at the current time. Most of 89bio's value examination focuses on studying past and present price action to predict the probability of 89bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 89bio's price. Additionally, you may evaluate how the addition of 89bio to your portfolios can decrease your overall portfolio volatility.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years